Predicting Success in the Endoscopic Management of Pediatric Vesicoureteral Reflux

Vesicoureteral reflux is a common cause of pediatric morbidity. Though traditionally managed using a limited number of therapeutic modalities, the last decade has witnessed countless surgical innovations for treating reflux. A major force behind this innovation is the increasing use of endoscopic in...

Full description

Saved in:
Bibliographic Details
Published in:Urology (Ridgewood, N.J.) N.J.), 2010-07, Vol.76 (1), p.195-198
Main Authors: Routh, Jonathan C, Reinberg, Yuri
Format: Article
Language:English
Subjects:
Biological and medical sciences
Cystoscopy
Dextrans - administration & dosage
Humans
Hyaluronic Acid - administration & dosage
Medical sciences
Nephrology. Urinary tract diseases
Prognosis
Remission Induction
Urinary system involvement in other diseases. Miscellaneous
Urinary tract. Prostate gland
Urology
Vesico-Ureteral Reflux - therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Vesicoureteral reflux is a common cause of pediatric morbidity. Though traditionally managed using a limited number of therapeutic modalities, the last decade has witnessed countless surgical innovations for treating reflux. A major force behind this innovation is the increasing use of endoscopic injection, which currently constitutes nearly half of all anti-reflux procedures performed in the United States. However, published success rates for injection vary dramatically. Despite a relative lack of comparative data, multiple studies have attempted to define the most important prognostic factors for injection success. This article is an attempt to summarize these findings.
ISSN:0090-4295
1527-9995
DOI:10.1016/j.urology.2009.09.017